Bans on Many CBD Products Loom This Year

The U.S. federal government is implementing a new law in November that will severely restrict the amount of THC, the psychoactive compound in cannabis, permitted in over-the-counter CBD products, prompting numerous industry groups and advocates to mount legal challenges against the regulation. This legislative action represents one of the most significant federal interventions in the burgeoning CBD market since its rapid expansion following the 2018 Farm Bill, which legalized hemp-derived products containing less than 0.3% THC. The new thresholds, which are significantly lower than current industry standards, would effectively remove many popular CBD items from store shelves, including those containing trace amounts of THC that consumers have relied on for therapeutic benefits. Industry analysts estimate that up to 60% of currently available CBD products could be forced off the market under the new guidelines, potentially disrupting a $24 billion industry that has grown exponentially in recent years. The regulation has sparked fierce opposition from CBD manufacturers, retailers, and consumer advocacy groups who argue that the limits are scientifically unfounded and economically damaging, with several companies already preparing lawsuits to block implementation.